Foundry Net Operating Assets Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1BKNG | BOOKING HOLDINGS INC | Industrials | $140.78B | 9.53% |
2FTNT | FORTINET INC | Technology | $118.40B | 8.01% |
3BNY | BANK OF NEW YORK MELLON CORP | Financial Services | $107.85B | 7.30% |
4MCK | MCKESSON CORP | Healthcare | $101.14B | 6.84% |
5HOOD | ROBINHOOD MARKETS INC | Financial Services | $90.01B | 6.09% |
6APO | APOLLO GLOBAL MANAGEMENT INC | Financial Services | $69.45B | 4.70% |
7MET | METLIFE INC | Financial Services | $60.48B | 4.09% |
8CAH | CARDINAL HEALTH INC | Healthcare | $53.52B | 3.62% |
9STT | STATE STREET CORP | Financial Services | $50.51B | 3.42% |
10AMP | AMERIPRISE FINANCIAL INC | Financial Services | $47.45B | 3.21% |
11LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.45B | 2.87% |
12NTRS | NORTHERN TRUST CORP | Financial Services | $34.17B | 2.31% |
13RJF | RAYMOND JAMES FINANCIAL INC | Financial Services | $32.81B | 2.22% |
14EXPE | EXPEDIA GROUP INC | Industrials | $32.26B | 2.18% |
15VRSN | VERISIGN INC | Technology | $25.27B | 1.71% |
16SYM | SYMBOTIC INC | Industrials | $24.86B | 1.68% |
17PFG | PRINCIPAL FINANCIAL GROUP INC | Financial Services | $24.61B | 1.67% |
18BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 1.08% |
19MEDP | MEDPACE HOLDINGS INC | Healthcare | $15.36B | 1.04% |
20CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 1.02% |
21NTNX | NUTANIX INC | Technology | $14.89B | 1.01% |
22CRBG | COREBRIDGE FINANCIAL INC | Financial Services | $14.56B | 0.99% |
23EQH | EQUITABLE HOLDINGS INC | Financial Services | $13.79B | 0.93% |
24AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.80% |
25W | WAYFAIR INC | Consumer Cyclical | $11.79B | 0.80% |
26UMBF | UMB FINANCIAL CORP | Financial Services | $11.09B | 0.75% |
27BPOP | POPULAR INC | Financial Services | $11.08B | 0.75% |
28CFR | CULLEN/FROST BANKERS INC | Financial Services | $10.15B | 0.69% |
29MANH | MANHATTAN ASSOCIATES INC | Technology | $9.66B | 0.65% |
30VOYA | VOYA FINANCIAL INC | Financial Services | $9.04B | 0.61% |
31OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.59% |
32JXN | JACKSON FINANCIAL INC | Financial Services | $8.76B | 0.59% |
33IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.56% |
34LNC | LINCOLN NATIONAL CORP | Financial Services | $8.08B | 0.55% |
35RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $7.56B | 0.51% |
36YOU | CLEAR SECURE INC | Technology | $7.49B | 0.51% |
37HNGE | HINGE HEALTH INC | Healthcare | $6.74B | 0.46% |
38CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.45% |
39PTCT | PTC THERAPEUTICS INC | Healthcare | $6.52B | 0.44% |
40CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.41% |
41STEP | STEPSTONE GROUP INC | Financial Services | $5.20B | 0.35% |
42TCBI | TEXAS CAPITAL BANCSHARES INC | Financial Services | $4.59B | 0.31% |
43ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.29% |
44FG | F&G ANNUITIES & LIFE INC | Financial Services | $4.25B | 0.29% |
45BOX | BOX INC | Technology | $4.22B | 0.29% |
46WSFS | WSFS FINANCIAL CORP | Financial Services | $4.16B | 0.28% |
47HGTY | HAGERTY INC | Financial Services | $4.13B | 0.28% |
48BANF | BANCFIRST CORP | Financial Services | $3.90B | 0.26% |
49BHF | BRIGHTHOUSE FINANCIAL INC | Financial Services | $3.77B | 0.26% |
50FHB | FIRST HAWAIIAN INC | Financial Services | $3.56B | 0.24% |
51ARX | ACCELERANT HOLDINGS | Financial Services | $2.95B | 0.20% |
52LUNR | INTUITIVE MACHINES INC | Industrials | $2.93B | 0.20% |
53AVPT | AVEPOINT INC | Technology | $2.80B | 0.19% |
54TNET | TRINET GROUP INC | Industrials | $2.74B | 0.19% |
55CUBI | CUSTOMERS BANCORP INC | Financial Services | $2.65B | 0.18% |
56IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.17% |
57SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.17% |
58SLDE | SLIDE INSURANCE HOLDINGS INC | Financial Services | $2.35B | 0.16% |
59HCI | HCI GROUP INC | Financial Services | $2.27B | 0.15% |
60AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.15% |
61PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.13% |
62LOB | LIVE OAK BANCSHARES INC | Financial Services | $1.97B | 0.13% |
63OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.96B | 0.13% |
64URGN | UROGEN PHARMA LTD | Healthcare | $1.96B | 0.13% |
65DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.13% |
66NSP | INSPERITY INC | Industrials | $1.89B | 0.13% |
67MQ | MARQETA INC | Technology | $1.85B | 0.13% |
68DCOM | DIME COMMUNITY BANCSHARES INC | Financial Services | $1.78B | 0.12% |
69TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.12% |
70CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.11% |
71IDT | IDT CORP | Communication Services | $1.57B | 0.11% |
72PWP | PERELLA WEINBERG PARTNERS | Financial Services | $1.48B | 0.10% |
73ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.10% |
74AIP | ARTERIS INC | Technology | $1.43B | 0.10% |
75TWFG | TWFG INC | Financial Services | $1.43B | 0.10% |
76WINA | WINMARK CORP | Consumer Cyclical | $1.39B | 0.09% |
77REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.09% |
78NVAX | NOVAVAX INC | Healthcare | $1.35B | 0.09% |
79BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.09% |
80LZ | LEGALZOOMCOM INC | Industrials | $1.33B | 0.09% |
81PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.32B | 0.09% |
82INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.09% |
83MCB | METROPOLITAN BANK HOLDING CORP | Financial Services | $1.22B | 0.08% |
84CCB | COASTAL FINANCIAL CORP | Financial Services | $1.20B | 0.08% |
85NBN | NORTHEAST BANCORP | Financial Services | $1.20B | 0.08% |
86MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.08% |
87WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.08% |
88SECZ | SECURITIZE CORP | Technology | $1.11B | 0.08% |
89UVE | UNIVERSAL INSURANCE HOLDINGS INC | Financial Services | $1.09B | 0.07% |
90ESQ | ESQUIRE FINANCIAL HOLDINGS INC | Financial Services | $1.06B | 0.07% |
91GRPN | GROUPON INC | Communication Services | $1.06B | 0.07% |
92FSBC | FIVE STAR BANCORP | Financial Services | $1.04B | 0.07% |
93CPF | CENTRAL PACIFIC FINANCIAL CORP | Financial Services | $1.02B | 0.07% |
94FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.07% |
95BBSI | BARRETT BUSINESS SERVICES INC | Industrials | $984M | 0.07% |
96VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.07% |
97ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.07% |
98TRST | TRUSTCO BANK CORP N Y | Financial Services | $960M | 0.06% |
99ROOT | ROOT INC | Financial Services | $944M | 0.06% |
100COUR | COURSERA INC | Consumer Defensive | $941M | 0.06% |
101SPFI | SOUTH PLAINS FINANCIAL INC | Financial Services | $880M | 0.06% |
102PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $873M | 0.06% |
103CCBG | CAPITAL CITY BANK GROUP INC | Financial Services | $861M | 0.06% |
104FCBC | FIRST COMMUNITY BANKSHARES INC | Financial Services | $848M | 0.06% |
105EGBN | EAGLE BANCORP INC | Financial Services | $835M | 0.06% |
106SMBK | SMARTFINANCIAL INC | Financial Services | $823M | 0.06% |
107AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.06% |
108HRTG | HERITAGE INSURANCE HOLDINGS INC | Financial Services | $821M | 0.06% |
109SHBI | SHORE BANCSHARES INC | Financial Services | $776M | 0.05% |
110GDOT | GREEN DOT CORP | Financial Services | $760M | 0.05% |
111DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.05% |
112CADL | CANDEL THERAPEUTICS INC | Healthcare | $746M | 0.05% |
113ALF | CENTURION ACQUISITION CORP | Industrials | $704M | 0.05% |
114AROW | ARROW FINANCIAL CORP | Financial Services | $687M | 0.05% |
115CASS | CASS INFORMATION SYSTEMS INC | Industrials | $686M | 0.05% |
116BCAL | CALIFORNIA BANCORP | Financial Services | $683M | 0.05% |
117ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.04% |
118RRBI | RED RIVER BANCSHARES INC | Financial Services | $644M | 0.04% |
119TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.04% |
120FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.04% |
121EVAC | EQV VENTURES ACQUISITION CORP II | Industrials | $598M | 0.04% |
122GPAT | GP-ACT III ACQUISITION CORP | Industrials | $596M | 0.04% |
123CBNK | CAPITAL BANCORP INC | Financial Services | $584M | 0.04% |
124GLRE | GREENLIGHT CAPITAL RE LTD | Financial Services | $566M | 0.04% |
125VSTM | VERASTEM INC | Healthcare | $530M | 0.04% |
126ZURA | ZURA BIO LTD | Healthcare | $518M | 0.04% |
127NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.03% |
128OBT | ORANGE COUNTY BANCORP INC | Financial Services | $504M | 0.03% |
129BSVN | BANK7 CORP | Financial Services | $485M | 0.03% |
130PAYS | PAYSIGN INC | Technology | $478M | 0.03% |
131ANSC | AGRICULTURE & NATURAL SOLUTIONS ACQUISITION CORP | Industrials | $475M | 0.03% |
132GTEN | GORES HOLDINGS X INC | Industrials | $472M | 0.03% |
133BMRC | BANK OF MARIN BANCORP | Financial Services | $468M | 0.03% |
134PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.03% |
135BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.03% |
136PCB | PCB BANCORP | Financial Services | $424M | 0.03% |
137TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.03% |
138BCAR | D BORAL ARC ACQUISITION I CORP | Industrials | $420M | 0.03% |
139QMCO | QUANTUM CORP | Technology | $419M | 0.03% |
140KFII | K&F GROWTH ACQUISITION CORP II | Industrials | $415M | 0.03% |
141CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.03% |
142NPAC | NEW PROVIDENCE ACQUISITION CORP III | Industrials | $399M | 0.03% |
143CCIX | CHURCHILL CAPITAL CORP IX | Industrials | $398M | 0.03% |
144TACO | BERTO ACQUISITION CORP | Industrials | $394M | 0.03% |
145MBAV | M3-BRIGADE ACQUISITION V CORP | Industrials | $391M | 0.03% |
146STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.03% |
147RDAG | REPUBLIC DIGITAL ACQUISITION CO | Industrials | $388M | 0.03% |
148WENN | WEN ACQUISITION CORP | Industrials | $387M | 0.03% |
149CEPT | CANTOR EQUITY PARTNERS II INC | Industrials | $376M | 0.03% |
150BCML | BAYCOM CORP | Financial Services | $371M | 0.03% |
151FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $365M | 0.02% |
152SDHI | SIDDHI ACQUISITION CORP (CAYMAN ISLANDS) | Industrials | $364M | 0.02% |
153CCII | COHEN CIRCLE ACQUISITION CORP II | Industrials | $360M | 0.02% |
154TACH | TITAN ACQUISITION CORP | Industrials | $360M | 0.02% |
155IPCX | INFLECTION POINT ACQUISITION CORP III | Industrials | $359M | 0.02% |
156KCHV | KOCHAV DEFENSE ACQUISITION CORP | Industrials | $356M | 0.02% |
157SOUL | SOULPOWER ACQUISITION CORP | Industrials | $352M | 0.02% |
158OYSE | OYSTER ENTERPRISES II ACQUISITION CORP | Industrials | $350M | 0.02% |
159TSBK | TIMBERLAND BANCORP INC | Financial Services | $343M | 0.02% |
160MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.02% |
161BEAG | BOLD EAGLE ACQUISITION CORP | Industrials | $335M | 0.02% |
162BLUW | BLUE WATER ACQUISITION CORP III | Industrials | $333M | 0.02% |
163CUB | LIONHEART HOLDINGS | Industrials | $331M | 0.02% |
164XRPN | ARMADA ACQUISITION CORP II | Industrials | $330M | 0.02% |
165RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.02% |
166FERA | FIFTH ERA ACQUISITION CORP I | Industrials | $326M | 0.02% |
167PCAP | PROCAP ACQUISITION CORP | Industrials | $326M | 0.02% |
168OBA | OXLEY BRIDGE ACQUISITION LTD | Industrials | $325M | 0.02% |
169SZZL | SIZZLE ACQUISITION CORP II | Industrials | $325M | 0.02% |
170CRAQ | CAL REDWOOD ACQUISITION CORP | Industrials | $324M | 0.02% |
171DRDB | ROMAN DBDR ACQUISITION CORP II | Industrials | $324M | 0.02% |
172MYFW | FIRST WESTERN FINANCIAL INC | Financial Services | $323M | 0.02% |
173PMTR | PERIMETER ACQUISITION CORP I | Industrials | $322M | 0.02% |
174FVCB | FVCBANKCORP INC | Financial Services | $321M | 0.02% |
175MSB | MESABI TRUST | Basic Materials | $320M | 0.02% |
176ALDF | ALDEL FINANCIAL II INC | Industrials | $320M | 0.02% |
177POLE | ANDRETTI ACQUISITION CORP II | Industrials | $318M | 0.02% |
178ATII | ARCHIMEDES TECH SPAC PARTNERS II CO | Industrials | $317M | 0.02% |
179JACS | JACKSON ACQUISITION CO II | Industrials | $317M | 0.02% |
180TVA | TEXAS VENTURES ACQUISITION III CORP | Industrials | $316M | 0.02% |
181MKTW | MARKETWISE INC | Technology | $314M | 0.02% |
182LPAA | LAUNCH ONE ACQUISITION CORP | Industrials | $313M | 0.02% |
183GRAF | GRAF GLOBAL CORP | Industrials | $310M | 0.02% |
184LPBB | LAUNCH TWO ACQUISITION CORP | Industrials | $309M | 0.02% |
185LWAC | LIGHTWAVE ACQUISITION CORP | Industrials | $308M | 0.02% |
186FCCO | FIRST COMMUNITY CORP | Financial Services | $307M | 0.02% |
187RAC | RITHM ACQUISITION CORP | Industrials | $307M | 0.02% |
188FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.02% |
189FDBC | FIDELITY D & D BANCORP INC | Financial Services | $305M | 0.02% |
190JENA | JENA ACQUISITION CORP II | Industrials | $301M | 0.02% |
191RAAQ | REAL ASSET ACQUISITION CORP | Industrials | $300M | 0.02% |
192NHIC | NEWHOLD INVESTMENT CORP III | Industrials | $295M | 0.02% |
193BACC | BLUE ACQUISITION CORP | Industrials | $293M | 0.02% |
194PACH | PIONEER ACQUISITION I CORP | Industrials | $293M | 0.02% |
195AACB | ARTIUS II ACQUISITION INC | Industrials | $292M | 0.02% |
196UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.02% |
197OVLY | OAK VALLEY BANCORP | Financial Services | $282M | 0.02% |
198TVAI | THAYER VENTURES ACQUISITION CORP II | Industrials | $281M | 0.02% |
199AXIN | AXIOM INTELLIGENCE ACQUISITION CORP 1 | Industrials | $280M | 0.02% |
200PAII | PYROPHYTE ACQUISITION CORP II | Industrials | $279M | 0.02% |
201CBNA | CHAIN BRIDGE BANCORP INC | Financial Services | $275M | 0.02% |
202SBXD | SILVERBOX CORP IV | Industrials | $275M | 0.02% |
203HVII | HENNESSY CAPITAL INVESTMENT CORP VII | Industrials | $273M | 0.02% |
204CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.02% |
205FXNC | FIRST NATIONAL CORP | Financial Services | $267M | 0.02% |
206OACC | OAKTREE ACQUISITION CORP III LIFE SCIENCES | Industrials | $263M | 0.02% |
207DMAA | DRUGS MADE IN AMERICA ACQUISITION CORP | Industrials | $259M | 0.02% |
208NTWO | NEWBURY STREET II ACQUISITION CORP | Industrials | $259M | 0.02% |
209FACT | FACT II ACQUISITION CORP | Industrials | $259M | 0.02% |
210PLMK | PLUM ACQUISITION CORP IV | Industrials | $257M | 0.02% |
211LTBR | LIGHTBRIDGE CORP | Industrials | $256M | 0.02% |
212SRZN | SURROZEN INC | Healthcare | $255M | 0.02% |
213VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.02% |
214COPL | COPLEY ACQUISITION CORP | Industrials | $248M | 0.02% |
215GTERA | GLOBA TERRA ACQUISITION CORP | Industrials | $246M | 0.02% |
216RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.02% |
217SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Industrials | $241M | 0.02% |
218MCGA | YORKVILLE ACQUISITION CORP | Industrials | $241M | 0.02% |
219GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.02% |
220DAAQ | DIGITAL ASSET ACQUISITION CORP | Industrials | $239M | 0.02% |
221DYNC | DYNAMIX CORP | Industrials | $238M | 0.02% |
222MACI | MELAR ACQUISITION CORP I | Industrials | $236M | 0.02% |
223TDAC | TRANSLATIONAL DEVELOPMENT ACQUISITION CORP | Industrials | $235M | 0.02% |
224INBK | FIRST INTERNET BANCORP | Financial Services | $233M | 0.02% |
225SVCC | STELLAR V CAPITAL CORP (CAYMAN ISLANDS) | Industrials | $229M | 0.02% |
226EFSI | EAGLE FINANCIAL SERVICES INC | Financial Services | $229M | 0.02% |
227UP | WHEELS UP EXPERIENCE INC | Industrials | $229M | 0.02% |
228CZWI | CITIZENS COMMUNITY BANCORP INC | Financial Services | $224M | 0.02% |
229ONCH | 1RT ACQUISITION CORP | Industrials | $222M | 0.02% |
230KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
231CFBK | CF BANKSHARES INC | Financial Services | $215M | 0.01% |
232GSHR | GESHER ACQUISITION CORP II | Industrials | $214M | 0.01% |
233EGHA | EGH ACQUISITION CORP | Industrials | $213M | 0.01% |
234CCAQ | COLLECTIVE ACQUISITION CORP | Industrials | $212M | 0.01% |
235KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
236IMUX | IMMUNIC INC | Healthcare | $207M | 0.01% |
237FCAP | FIRST CAPITAL INC | Financial Services | $205M | 0.01% |
238DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.01% |
239FIGX | FIGX CAPITAL ACQUISITION CORP | Industrials | $199M | 0.01% |
240RBKB | RHINEBECK BANCORP INC | Financial Services | $190M | 0.01% |
241HNVR | HANOVER BANCORP INC | Financial Services | $179M | 0.01% |
242ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
243MNSB | MAINSTREET BANCSHARES INC | Financial Services | $172M | 0.01% |
244RANG | RANGE CAPITAL ACQUISITION CORP | Industrials | $171M | 0.01% |
245SBFG | SB FINANCIAL GROUP INC | Financial Services | $170M | 0.01% |
246TAVI | TAVIA ACQUISITION CORP | Industrials | $170M | 0.01% |
247NUCL | EAGLE NUCLEAR ENERGY CORP | Basic Materials | $166M | 0.01% |
248FGBI | FIRST GUARANTY BANCSHARES INC | Financial Services | $164M | 0.01% |
249OWLT | OWLET INC | Healthcare | $162M | 0.01% |
250SPEG | SILVER PEGASUS ACQUISITION CORP | Industrials | $158M | 0.01% |
251INAC | INDIGO ACQUISITION CORP | Industrials | $152M | 0.01% |
252UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.01% |
253PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
254VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.01% |
255JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
256IPEX | INFLECTION POINT ACQUISITION CORP V | Industrials | $126M | 0.01% |
257PCSC | PERCEPTIVE CAPITAL SOLUTIONS CORP | Industrials | $123M | 0.01% |
258BOTJ | BANK OF THE JAMES FINANCIAL GROUP INC | Financial Services | $121M | 0.01% |
259SFBC | SOUND FINANCIAL BANCORP INC | Financial Services | $120M | 0.01% |
260SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
261PGAC | PANTAGES CAPITAL ACQUISITION CORP | Industrials | $118M | 0.01% |
262CHAR | CHARLTON ARIA ACQUISITION CORP | Industrials | $116M | 0.01% |
263TZOO | TRAVELZOO | Communication Services | $113M | 0.01% |
264RVSB | RIVERVIEW BANCORP INC | Financial Services | $107M | 0.01% |
265QSEA | QUARTZSEA ACQUISITION CORP | Industrials | $107M | 0.01% |
266SPKL | SPARK I ACQUISITION CORP | Industrials | $105M | 0.01% |
267CHPG | CHAMPIONSGATE ACQUISITION CORP | Industrials | $104M | 0.01% |
268NOEM | CO2 ENERGY TRANSITION CORP | Industrials | $101M | 0.01% |
269VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.01% |
270LCCC | LAKESHORE ACQUISITION III CORP | Industrials | $93M | 0.01% |
271AUBN | AUBURN NATIONAL BANCORPORATION INC | Financial Services | $93M | 0.01% |
272FUSB | FIRST US BANCSHARES INC | Financial Services | $92M | 0.01% |
273SIMA | SIM ACQUISITION CORP I | Industrials | $90M | 0.01% |
274ORIQ | ORIGIN INVESTMENT CORP I | Industrials | $89M | 0.01% |
275FGMC | FG MERGER II CORP | Industrials | $86M | 0.01% |
276CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.01% |
277NRXS | NEURAXIS INC | Healthcare | $84M | 0.01% |
278FVN | FUTURE VISION II ACQUISITION CORP | Industrials | $83M | 0.01% |
279WTG | WINTERGREEN ACQUISITION CORP | Industrials | $76M | 0.01% |
280CLNN | CLENE INC | Healthcare | $76M | 0.01% |
281OPHC | OPTIMUMBANK HOLDINGS INC | Financial Services | $74M | 0.01% |
282LVO | LIVEONE INC | Communication Services | $72M | 0.00% |
283SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.00% |
284HFBL | HOME FEDERAL BANCORP INC OF LOUISIANA | Financial Services | $70M | 0.00% |
285LNSR | LENSAR INC | Healthcare | $70M | 0.00% |
286KVAC | KEEN VISION ACQUISITION CORP | Industrials | $68M | 0.00% |
287EURK | EUREKA ACQUISITION CORP | Industrials | $60M | 0.00% |
288CAPN | CAYSON ACQUISITION CORP | Industrials | $59M | 0.00% |
289EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
290UYSC | UY SCUTI ACQUISITION CORP | Industrials | $56M | 0.00% |
291FSHP | FLAG SHIP ACQUISITION CORP | Industrials | $56M | 0.00% |
292IBAC | IB ACQUISITION CORP | Industrials | $54M | 0.00% |
293RIBB | RIBBON ACQUISITION CORP | Industrials | $54M | 0.00% |
294INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.00% |
295XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
296BKHA | BLACK HAWK ACQUISITION CORP | Industrials | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.48T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 93% toward Large, 63% toward Growth. +6% unclassified (38 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 18.8% | 14.0% |
| 3 yearsp.a. | 23.9% | -8.0% |
| 5 yearsp.a. | 13.7% | -0.9% |
| 10 yearsp.a. | 16.3% | 2.4% |
| Since inceptionp.a. | 10.0% | 4.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 17.5% | 10.9% |
| 2025 | 21.9% | 0.9% |
| 2024 | 25.6% | -33.0% |
| 2023 | 30.2% | 4.5% |
| 2022 | -24.7% | 19.8% |
| 2021 | 38.3% | 10.7% |
| 2020 | 1.0% | -13.9% |
| 2019 | 21.8% | -0.4% |
| 2018 | -8.7% | 4.4% |
| 2017 | 35.6% | 8.6% |
| 2016 | 18.5% | 14.5% |
| 2015 | 3.9% | 8.3% |
| 2014 | 10.4% | 4.9% |
| 2013 | 53.8% | 19.9% |
| 2012 | 18.5% | 4.4% |
| 2011 | -6.4% | -3.3% |
| 2010 | 14.6% | 0.8% |
| 2009 | 24.9% | -11.0% |
| 2008 | -41.5% | 28.4% |
| 2007 | 4.9% | -7.6% |
| 2006 | 11.2% | 0.8% |
| 2005 | 6.4% | -1.0% |
| 2004 | 15.7% | -0.4% |
| 2003 | 38.9% | 5.1% |
| 2002 | -15.2% | 17.8% |
| 2001 | -15.8% | 18.9% |
| 2000 | 6.6% | 48.2% |
| 1999 | 27.7% | -19.3% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Net Operating Assets Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Net Operating Assets signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.